On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Playing a Leadership Role in Point-of-Care Diagnostics Space

  • Avricore is a leader in the health diagnostics space offering the most sophisticated and complete solution for pharmacy today
  • The company is also leading a charge aimed at saving lives and money spent on health care
  • Avricore partnered with Abbott Diagnostics becoming the first third-party technology company to hold distribution agreements with the manufacturer
  • Avricore is currently entering a period of epic growth

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF), a health diagnostics technology innovator, is a leader in the point-of-care (“POC”) diagnostics space and a company of several firsts. Through its flagship platform and eponymous wholly owned subsidiary, HealthTab(TM), Avricore has provided a proactive approach in the fight against diseases such as prediabetes, diabetes, SARS-CoV-2 (COVID-19), Influenza A and B, strep, and RSV (https://ibn.fm/DPsLu).

Speaking during an interview with Stuart Smith as part of a recent Bell2Bell Podcast episode (https://ibn.fm/61OLh), AVCR CEO Hector Bremner summed up the company’s unique diagnostics and cloud-based technology by saying, “We are really excited to be leaders in the field. There’s nobody quite like us. There are people that do parts of what we do, but we have brought the most sophisticated and most complete solution for pharmacy today.” 

Better known as HealthTab, the solution is a fully automated, turnkey POC testing system that combines high-quality analyzers from manufacturers such as Abbott Diagnostics and Abaxis Global Diagnostics with a cloud-based solution, creating a network that benefits pharmacies and patients alike. 

For patients, the HealthTab system, through the analyzers, tests multiple key biomarkers associated with chronic and infectious diseases and subsequently generates lab-accurate, real-time results that patients can view via the system’s consumer-facing interface. For pharmacies, Bremner noted, Avricore provides an additional revenue-generating opportunity in the form of cognitive pharmacy services.

In its vanguard role, Avricore is leading a charge that involves leveraging early detection and screening to save lives as well as the amount of money spent in health care. With early diagnosis having been proven as instrumental in reducing mortality and cardiovascular morbidity resulting from Type 2 diabetes (https://ibn.fm/7Htz0), as well as death caused by COVID-19 (https://ibn.fm/982Ml), HealthTab is indeed a boon.

“I’ve always really believed that we need a true health care system [in Canada] that values early detection and screening if we really want to make sure that we’re not only saving lives but saving health care dollars in the future. We’re really passionate about leading this charge,” continued Bremner.

Avricore’s leadoff stature also came into focus when it partnered with Abbott Diagnostics as part of a distribution agreement. Bremner, who described the partnership as groundbreaking, noted that Abbott does not ordinarily do distribution agreements for their technology with third-party technology companies like AVCR.

“Normally, to distribute Abbott technologies at this level, you have to be a fairly large distributor of health care technologies to begin with. We were extremely fortunate to pioneer this agreement and really break ground to see what was possible as a value-added reseller to bring our technology in combination with theirs,” observed Bremner.

Bremner noted that the partnership accelerated Avricore’s growth, further pointing out that the company is ideally poised for a great finish to the current year and continued growth through 2023, having repaid its debts and raised about $4.5 million this year.

Avricore is committed to becoming the world’s largest health diagnostics company. With a primary focus on developing a network of POC analyzers that utilize its HealthTab software in community pharmacy, the company is staking a claim as a leader in the space.

For more information, visit the company’s website at www.AvricoreHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to AVCRF are available in the company’s newsroom at https://ibn.fm/AVCRF

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Archives

Select A Month
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • January 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • January 2009
  • December 2008
  • November 2008
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008
  • February 2008
  • January 2008
  • December 2007
  • November 2007
  • October 2007
  • September 2007
  • August 2007
  • July 2007
  • June 2007
  • May 2007
  • April 2007
  • March 2007
  • February 2007
  • January 2007
  • December 2006
  • November 2006
  • October 2006
  • September 2006
  • August 2006
  • July 2006
  • June 2006
  • May 2006
  • April 2006
  • March 2006
  • January 2006
  • December 2005
  • October 2005
  • September 2005
  • Market Basics

    New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

    The Basics

    Newsletter Publishers

    Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

    Register

    Public Companies

    Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

    Get Covered